Clinical Trial Details
EORTC-30952
Back to Clinical Trials Database
Quarter dose BCG on a papillary superficial bladder cancer. A phase II study on a marker lesion
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 22-Jan-1996 Date Step1 close: 01-May-1998 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 40 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
